Description
PET/CT RADIOPHARMACEUTICALS
First action · last action
2018-10-01 · 2025-03-06
Transactions
23
First transaction's obligation
$153,504
Base + all options value (sum of deltas)
$2,343,583
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 23 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-10-01+$153,504= $153,504
- Mod P000012019-06-27-$49,000= $104,504
- Mod P000022019-09-11+$0= $104,504
- Mod P000032019-10-01+$155,349= $259,853
- Mod P000042019-11-12+$169= $260,022
- Mod P000052020-08-19-$55,000= $205,022
- Mod P000062020-09-18+$0= $205,022
- Mod P000072020-10-01+$155,964= $360,986
- Mod P000082020-12-02+$880= $361,866
- Mod P000092021-03-22+$45,000= $406,866
- Mod P000102021-09-09+$0= $406,866
- Mod P000112021-10-01+$164,310= $571,176
- Mod P000122021-10-25+$125,856= $697,032
- Mod P000132022-02-23-$72,432= $624,600
- Mod P000142022-05-18+$581,000= $1,205,600
- Mod P000152022-09-27+$0= $1,205,600
- Mod P000162022-10-01+$880,203= $2,085,803
- Mod P000172023-02-08+$28,294= $2,114,097
- Mod P000182023-03-06+$1,405= $2,115,502
- Mod P000192023-09-26+$252,511= $2,368,013
- Mod P000202024-01-29-$26,798= $2,341,215
- Mod P000212024-06-17+$2,500= $2,343,715
- Mod P000222025-03-06-$132= $2,343,583
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-10-01 | +$153,504 | $153,504 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2019-06-27 | −$49,000 | $104,504 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00002· EXERCISE AN OPTION | 2019-09-11 | +$0 | $104,504 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00003· FUNDING ONLY ACTION | 2019-10-01 | +$155,349 | $259,853 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00004· FUNDING ONLY ACTION | 2019-11-12 | +$169 | $260,022 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00005· FUNDING ONLY ACTION | 2020-08-19 | −$55,000 | $205,022 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00006· EXERCISE AN OPTION | 2020-09-18 | +$0 | $205,022 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00007· EXERCISE AN OPTION | 2020-10-01 | +$155,964 | $360,986 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00008· FUNDING ONLY ACTION | 2020-12-02 | +$880 | $361,866 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-03-22 | +$45,000 | $406,866 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00010· EXERCISE AN OPTION | 2021-09-09 | +$0 | $406,866 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00011· EXERCISE AN OPTION | 2021-10-01 | +$164,310 | $571,176 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-10-25 | +$125,856 | $697,032 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00013· FUNDING ONLY ACTION | 2022-02-23 | −$72,432 | $624,600 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00014· FUNDING ONLY ACTION | 2022-05-18 | +$581,000 | $1,205,600 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00015· EXERCISE AN OPTION | 2022-09-27 | +$0 | $1,205,600 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00016· EXERCISE AN OPTION | 2022-10-01 | +$880,203 | $2,085,803 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-02-08 | +$28,294 | $2,114,097 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00018· FUNDING ONLY ACTION | 2023-03-06 | +$1,405 | $2,115,502 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00019· FUNDING ONLY ACTION | 2023-09-26 | +$252,511 | $2,368,013 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00020· FUNDING ONLY ACTION | 2024-01-29 | −$26,798 | $2,341,215 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00021· FUNDING ONLY ACTION | 2024-06-17 | +$2,500 | $2,343,715 | PET/CT RADIOPHARMACEUTICALS |
| Mod P00022· FUNDING ONLY ACTION | 2025-03-06 | −$132 | $2,343,583 | PET/CT RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JV1AHJHGUGG3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0392 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $357,066 | FY2026 |
| 36C25526N0245 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,172,834 | FY2026 |
| 36C24226N0463 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $624,017 | FY2026 |
| 36C24226N0388 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $830,796 | FY2026 |
| 36C24226D0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25026P0310 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $347,000 | FY2026 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926F0310 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0409 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $34,735 | FY2026 |
| 36C25926F0264 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0384 | SIRTEX MEDICAL INC | NETWORK CONTRACT OFFICE 19 (36C259) | $245,194 | FY2026 |
| 36C25926P0553 | COSETTE PHARMACEUTICALS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $3,439 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25919P0002_3600_-NONE-_-NONE- · retrieved 2026-09-26.